Antioxidant therapy for muscular dystrophy: caveat lector!

E-ISSN： 1469-7793|596|4|737-738

ISSN： 0022-3751

Source： THE JOURNAL OF PHYSIOLOGY, Vol.596, Iss.4, 2018-02, pp. : 737-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

PKC Proteins and Muscular Dystrophy

By Gobbi Giuliana Galli Daniela Carubbi Cecilia Neri Luca Maria Masselli Elena Pozzi Giulia Vitale Marco Mirandola Prisco

Journal of Functional Morphology and Kinesiology, Vol. 3, Iss. 1, 2018-02 ,pp. : 12-12

MDPI

Access to resources Recommend Favorite

Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy

By Okada Takashi Takeda Shin'ichi

Pharmaceuticals, Vol. 6, Iss. 7, 2013-06 ,pp. : 813-836

MDPI

Access to resources Recommend Favorite

Molecular basis of facioscapulohumeral muscular dystrophy

By Tupler R. Gabellini D.

Cellular and Molecular Life Sciences CMLS, Vol. 61, Iss. 5, 2004-03 ,pp. : 557-566

Springer Publishing Company

Access to resources Recommend Favorite

Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 231, Iss. 1, 2016-01 ,pp. : 224-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 21-9541, Iss. 1, 2016-01 ,pp. : 224-232

John Wiley & Sons Inc

Access to resources Recommend Favorite